首页> 外文OA文献 >Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene
【2h】

Functional and phenotypic studies of two variants of a human mast cell line with a distinct set of mutations in the c-kit proto-oncogene

机译:对人类肥大细胞系的两个变体进行功能和表型研究,该变体在c-kit原癌基因中具有独特的突变集

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

The human mast cell line (HMC)-1 cell line is growth-factor independent because of a constitutive activity of the receptor tyrosine kinase Kit. Such deregulated Kit activity has also been suggested causative in gastrointestinal stromal tumours (GISTs) and mastocytosis. HMC-1 is the only established continuously growing human mast cell line and has therefore been widely employed for in vitro studies of human mast cell biology. In this paper we describe two sublines of HMC-1, named HMC-1560 and HMC-1560,816, with different phenotypes and designated by the locations of specific mutations in the c-kit proto-oncogene. Activating mutations in the Kit receptor were characterized using the pyrosequencing™ method. Both sublines have a heterozygous T to G mutation at codon 560 in the juxtamembrane region of the c-kit gene causing an amino acid substitution of Gly-560 for Val. In contrast, only HMC-1560,816 cells have the c-kitV816 mutation found in mast cell neoplasms causing an Asp→Val substitution in the intracellular kinase domain. Kit was constitutively phosphorylated on tyrosine residues and associated with phosphatidylinositol 3′-kinase (PI 3-kinase) in both variants of HMC-1, but this did not lead to a constitutive phosphorylation of Akt or extracellular regulated protein kinase (ERK), which are signalling molecules normally activated by the interaction of stem cell factor (SCF) with Kit. The documentation and characterization of two sublines of HMC-1 cells provides both information on the biological consequences of mutations in Kit and recognition of the availability of what in reality are two distinct cultured human mast cell lines.
机译:人类肥大细胞系(HMC)-1细胞系由于受体酪氨酸激酶试剂盒的组成活性而与生长因子无关。还暗示了这种放慢的Kit活性在胃肠道间质瘤(GIST)和肥大细胞增多症中起因。 HMC-1是唯一建立的持续增长的人类肥大细胞系,因此已广泛用于人类肥大细胞生物学的体外研究。在本文中,我们描述了HMC-1的两个亚系,分别为HMC-1560和HMC-1560,816,它们具有不同的表型,并由c-kit原癌基因中特定突变的位置指定。使用焦磷酸测序™方法对Kit受体中的激活突变进行了表征。这两个亚系在c-kit基因近膜区域的密码子560处均具有杂合的T至G突变,导致Gly-560的氨基酸被Val取代。相反,仅HMC-1560,816细胞具有在肥大细胞肿瘤中发现的c-kitV816突变,从而引起细胞内激酶结构域中的Asp→Val取代。在HMC-1的两个变体中,该试剂盒在酪氨酸残基上均组成性磷酸化,并与磷脂酰肌醇3'-激酶(PI 3-激酶)相关,但这并未导致Akt或组成性细胞外调节蛋白激酶(ERK)的组成性磷酸化。是通常通过干细胞因子(SCF)与Kit相互作用激活的信号分子。 HMC-1细胞的两个亚系的文献记录和表征既提供了有关Kit中突变的生物学后果的信息,又提供了对两种不同培养的人类肥大细胞系的实用性的认识。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号